ijms-logo

Journal Browser

Journal Browser

Interrelation between Heart Failure and Chronic Kidney Disease: A Focus on Molecule Mechanisms

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 June 2024 | Viewed by 585

Special Issue Editors


E-Mail Website
Guest Editor
Nephrology and Dialysis Unit, « Renato Dulbecco » Hospital of Catanzaro, Catanzaro, Italy
Interests: chronic kidney disease; hemodialysis; vascular access; cardiorenal syndrome; heart biomarkers; miRNA

E-Mail Website
Guest Editor
Department of Medical and Surgical Sciences-Renal Unit, "Magna Graecia" University, Campus Salvatore Venuta, Viale Europa, 88100 Catanzaro, Italy
Interests: cardiovascular risk in renal patients; vascular function in uremia-biomarkers in renal disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The heart and kidney are interconnected, and this interaction is bidirectional because the acute or chronic dysfunction of the heart or kidneys can induce acute or chronic dysfunction in the other organ.

The term "cardiorenal syndrome" has been applied to these interactions.

Patients with heart failure (HF) have a high risk of reduced glomerular filtration rate, and patients with chronic kidney disease have an increased risk of both atherosclerotic cardiovascular disease, and HF.

Mortality is higher in patients with HF and chronic kidney disease and cardiovascular disease is responsible for up to 50 percent of deaths in patients with renal failure.

Up to 70%–80% of chronic hemodialysis patients display abnormal concentric or eccentric left ventricular hypertrophy (LVH). Cardiac fibrosis due to collagen deposition between the capillaries and cardiomyocytes often overlays LVH, leading to ventricular wall dilatation and diastolic dysfunction: a threatening condition known as “uremic cardiomyopathy”.

The pathogenesis of this interconnection is complex and not yet entirely clear.

Thus, this Special Issue entitled ‘Interrelation Between Heart Failure and Chronic Kidney Disease: A Focus on Molecule Mechanisms’ discusses recent advances in molecular mechanisms involved in the interconnection between the heart and kidney. Topics related to both original and reviewed articles are welcome.

Dr. Pierangela Presta
Dr. Coppolino Giuseppe
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiorenal syndrome
  • heart failure
  • chronic kidney disease
  • uremia
  • left ventricular hypertrophy
  • biomarkers

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 479 KiB  
Article
N-Terminal Pro-Brain Natriuretic Peptide Correlates with Ghrelin and Acyl-Ghrelin in Pre-Dialysis Chronic Kidney Disease
by Crina Claudia Rusu, Florin Anton, Ana Valea and Cosmina Ioana Bondor
Int. J. Mol. Sci. 2024, 25(11), 5696; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms25115696 - 23 May 2024
Viewed by 253
Abstract
Pro-B amino-terminal natriuretic peptide (NT-proBNP) is a diagnostic marker for heart failure (HF), a severe complication of chronic kidney disease (CKD). However, its significance in CKD is not clear, as other factors, such as renal function, may also have an impact. Recent studies [...] Read more.
Pro-B amino-terminal natriuretic peptide (NT-proBNP) is a diagnostic marker for heart failure (HF), a severe complication of chronic kidney disease (CKD). However, its significance in CKD is not clear, as other factors, such as renal function, may also have an impact. Recent studies have shown that ghrelin treatment is effective in HF in the general population, but the impact of ghrelin on cardiac function in CKD patients is still unknown. Our study aimed to investigate the factors associated with NT-proBNP in pre-dialysis CKD patients and to evaluate the correlation between NT-proBNP and ghrelin and acyl-ghrelin, molecules determined using ELISA methods. In a cross-sectional observational study, we included 80 patients with pre-dialysis CKD, with a mean age of 68 years and 50% men. The median values for NT-proBNP were 351.8 pg/mL, for acyl ghrelin 16.39 pg/mL, and for ghrelin 543.32 pg/mL. NT-proBNP was correlated with ghrelin (p = 0.034, r = 0.24), acyl-ghrelin (p = 0.033, r = −0.24), estimated glomerular filtration rate (p = 0.027, r = −0.25), serum urea (p = 0.006, r = 0.31), and ferritin (p = 0.041, r = 0.28). In multivariate analysis, ghrelin (p = 0.040) and blood urea (p = 0.040) remained significant predictors for NT-proBNP levels. NT-proBNP was a significant predictor for acyl-ghrelin (p = 0.036). In conclusion, in pre-dialysis CKD patients, a high value of NT-proBNP was associated with a high value of total ghrelin and a low value of acyl-ghrelin. Full article
Back to TopTop